Australia markets open in 6 hours 35 minutes

TherapeuticsMD, Inc. (29TA.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
1.7300-0.0100 (-0.57%)
As of 04:05PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
69,366
69,963
2,573
64,872
Cost of revenue
0
1,397
1,402
15,975
Gross profit
69,366
68,566
1,171
48,897
Operating expenses
Research development
-
0
0
10,432
Selling general and administrative
18,963
57,903
80,748
194,006
Total operating expenses
18,364
57,903
80,748
204,438
Operating income or loss
51,002
10,663
-79,577
-155,541
Interest expense
-
-
22,568
26,049
Total other income/expenses net
-8,592
-9,589
272
598
Income before tax
42,295
1,074
-79,305
-183,524
Income tax expense
-
0
0
0
Income from continuing operations
42,295
1,074
-79,305
-183,524
Net income
68,307
111,997
-172,415
-183,524
Net income available to common shareholders
68,307
111,997
-172,415
-183,524
Basic EPS
7.63
12.41
-21.66
-33.50
Diluted EPS
7.18
11.96
-21.66
-33.50
Basic average shares
10,051
9,028
7,960
5,513
Diluted average shares
10,389
9,366
7,960
5,513